1 (Images 1)
Mesalamine Tablet, Delayed Release
Product Images NDC 0480-7750
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Mesalamine (NDC 0480-7750). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Teva Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
180 (Images 2)
This text provides information on a medication called Mesalamine in its delayed-release tablet form. It mentions the recommended dosage for treating moderately active ulcerative colitis and advises not to substitute one tablet for another. The text also includes the NDC (National Drug Code) number for the medication.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
